These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Transforming growth factor beta (TGF beta) activity in urine of patients with glomerulonephritis. Dominguez GC, Costa RS, Dantas M, Kimachi T, Coimbra TM. Braz J Med Biol Res; 1995 Oct; 28(10):1061-4. PubMed ID: 8634677 [Abstract] [Full Text] [Related]
5. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression]. Bobkova IN, Chebotareva NV, Kozlovskaia LV, Varshavskiĭ VA, Golitsyna EP. Ter Arkh; 2006 Oct; 78(5):9-14. PubMed ID: 16889042 [Abstract] [Full Text] [Related]
11. Urinary excretion of TGF-beta 1, PDGF-BB and fibronectin in insulin-dependent diabetes mellitus patients. Fagerudd JA, Groop PH, Honkanen E, Teppo AM, Grönhagen-Riska C. Kidney Int Suppl; 1997 Dec 01; 63():S195-7. PubMed ID: 9407457 [Abstract] [Full Text] [Related]
12. Urinary glycosaminoglycan composition in chronic glomerulonephritis. De Muro P, Faedda R, Satta A, Finetti D, Masala A, Cigni A, Sanna GM, Cherchi GM. J Nephrol; 2005 Dec 01; 18(2):154-60. PubMed ID: 15931643 [Abstract] [Full Text] [Related]
13. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis. Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G. Am J Kidney Dis; 1998 Mar 01; 31(3):453-63. PubMed ID: 9506682 [Abstract] [Full Text] [Related]
15. Urine excretion of transforming growth factor-beta1 in chronic allograft nephropathy. Boratyńska M. Ann Transplant; 1999 Mar 01; 4(2):23-8. PubMed ID: 10850587 [Abstract] [Full Text] [Related]
16. Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy. Maas RJ, van den Brand JA, Waanders F, Meijer E, Goor van H, Peters HP, Hofstra JM, Wetzels JF. Ann Clin Biochem; 2016 Jan 01; 53(Pt 1):51-7. PubMed ID: 25762211 [Abstract] [Full Text] [Related]
17. Endopyelotomy failure is associated with reduced urinary transforming growth factor-beta1 levels in patients with upper urinary tract obstruction. Liatsikos EN, Dinlenc CZ, Bernardo NO, Kapoor R, Jabbour ME, Smith AD, Kushner L. J Endourol; 2001 Aug 01; 15(6):567-70. PubMed ID: 11552777 [Abstract] [Full Text] [Related]
18. Transforming growth factor beta 1 in renal allograft recipients. Coupes BM, Newstead CG, Short CD, Brenchley PE. Transplantation; 1994 Jun 27; 57(12):1727-31. PubMed ID: 8016876 [Abstract] [Full Text] [Related]
19. Stimulation of urinary TGF-beta and isoprostanes in response to hyperglycemia in humans. McGowan TA, Dunn SR, Falkner B, Sharma K. Clin J Am Soc Nephrol; 2006 Mar 27; 1(2):263-8. PubMed ID: 17699215 [Abstract] [Full Text] [Related]
20. mRNA expression of glomerular basement membrane proteins and TGF-beta1 in human membranous nephropathy. Kim TS, Kim JY, Hong HK, Lee HS. J Pathol; 1999 Nov 27; 189(3):425-30. PubMed ID: 10547606 [Abstract] [Full Text] [Related] Page: [Next] [New Search]